Home

Howard W. Robin, President & CEO: Nektar Therapeutics NKTR Sell · Filed 06/18

Trade details

Type
Insider sale
Amount
$334,455
Shares · price
5,500 sh · $60.81 a share
Held after
59,545 sh
Trade date
26/06/17
Filed
26/06/18
Days to filing
1 days

Sold 8.5% of holdings

Share of holding sold
8.5%

Nektar Therapeutics trades, last 26 weeks

What else happened in Nektar Therapeutics around then

Filed or reported within 30 days of the trade day · 05/18~07/17

Howard W. Robin's recent trades

  • Howard W. Robin

    Planned saleNektar Therapeutics

    $30.1K

    Filed 08/18

  • Howard W. Robin

    Sell10b5-1 planNektar Therapeutics

    $318K

    Filed 06/18

  • Howard W. Robin

    Sell10b5-1 planNektar Therapeutics

    $285.2K

    Filed 06/18

  • Howard W. Robin

    Sell10b5-1 planNektar Therapeutics

    $277.4K

    Filed 06/18

  • Howard W. Robin

    Planned sale10b5-1 planNektar Therapeutics

    $602.7K

    Filed 06/17